TPD & Induced Proximity Summit Leaderboard
  • Sunday, August 2, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 830

Author

Pharma Journalist 8978 posts 0 comments

Bristol-Myers Squibb to Acquire IFM Therapeutics

Aug 6, 2017
Bristol-Myers Squibb Company and IFM Therapeutics (IFM) announced that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the…
Read More...

Takeda and Molecular Templates Announce Multi-Target Research and Licensing Collaboration

Aug 6, 2017
Takeda Pharmaceutical Company Limited and Molecular Templates, Inc. today announced a collaboration agreement for oncology drug discovery programs. The collaboration will apply…
Read More...

FDA Grants Orphan Drug Designation to Omeros’ OMS721 for Treatment of IgA Nephropathy

Aug 6, 2017
Omeros Corporation announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of Immunoglobulin A (IgA) nephropathy.…
Read More...

Achieve Life Sciences Announces Closing of Merger with OncoGenex Pharmaceuticals

Aug 3, 2017
Achieve Life Sciences, Inc. announced the closing of its previously announced merger with OncoGenex Pharmaceuticals, as a result of which the stockholders of Achieve have become the…
Read More...

Collidion Acquires 80% Stake in Plex Pharmaceuticals

Aug 3, 2017
Collidion Inc. and CalAsia Pharmaceuticals, Inc., DBA Plex Pharmaceuticals announced that they have entered into a definitive agreement under which Collidion will acquire an 80% equity…
Read More...

Takeda and Cardurion Pharmaceuticals Launch Cardiovascular Development Partnership

Aug 3, 2017
Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals announced the creation of a new cardiovascular development partnership. Cardurion, a recently launched Boston-area…
Read More...

Flex Pharma launches ALS phase 2 study with FLX-787 in US

Aug 2, 2017
Flex Pharma has initiated a Phase 2 randomized, controlled, double-blinded, parallel design trial in the US. The COMMEND trial will evaluate FLX-787, the Company’s co-activator of…
Read More...

SiO2 Medical Products and Sanaria Sign Agreement for Cryogenic Vials for PfSPZ Vaccine to Prevent…

Aug 2, 2017
SiO2 Medical Products, Inc., a U.S.-based designer, developer, manufacturer, and supplier of pharmaceutical packaging, labware, and consumables products, and Sanaria Inc., a U.S.-based…
Read More...

Generex Announces Collaboration with Merck to Evaluate KEYTRUDA (pembrolizumab)

Aug 1, 2017
Generex Biotechnology Corporation announced that its wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com) has entered into a clinical trial collaboration agreement…
Read More...

Zoetis Completes Acquisition of Nexvet Biopharma

Aug 1, 2017
Zoetis Inc. and Nexvet Biopharma plc announced that Zoetis has completed the acquisition of Nexvet, a biologic therapeutics company developing a pipeline of monoclonal antibody (mAb)…
Read More...
Prev Next
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • miRecule, EMS Unit Partner on RNA Delivery Technologies
  • Pfizer Reports Positive Phase 3 Results for LITFULO in Vitiligo
  • Resilience Expands Lilly Partnership With $750 Million Ohio Investmen
  • AbCellera, Vertex Partner on T-Cell Engagers for Autoimmune Diseases
  • EVERSANA to Commercialize Innovacell’s ICEF15 in the US

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.